USD 0.8 billion
Report ID:
SQMIG35D2138 |
Region:
Global |
Published Date: February, 2025
Pages:
219
|Tables:
90
|Figures:
78
Brachytherapy Market size was valued at USD 0.8 billion in 2023 and is poised to grow from USD 0.87 billion in 2024 to USD 1.64 billion by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).
The growth of the global brachytherapy market is expected to be driven by factors such as the increasing prevalence of cancer, advancements in technology, and a significant rise in the adoption of brachytherapy. Brachytherapy is a form of radiation therapy where radioactive materials are placed inside the body using catheters to treat cancer.
Brachytherapy is a highly effective treatment for localized tumors, utilizing artificially produced radionuclides such as Caesium-137, Iridium-192, Gold-198, Iodine-125, and Palladium-103. The International Agency for Research on Cancer (IARC) estimates that the global incidence of cancer is around 19.3 million and is projected to increase to 24.6 million by 2030.
This growing cancer burden is a major driver for the market. Radiation therapy can be used for various purposes, including prophylactic, palliative, or curative treatment, either as monotherapy or in combination with surgery, immunotherapy, or chemotherapy. The broad range of applications has led to increased adoption by physicians. Recent advancements in radiation therapy techniques enable the precise delivery of high doses to the target area while minimizing damage to surrounding healthy tissues. This has significantly improved localized tumor control and cure rates, thereby increasing the demand for radiation therapy.
US Brachytherapy Market is poised to grow at sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 0.8 billion
Largest Segment
HDR
Fastest Growth
HDR
Growth Rate
8.3% CAGR
To get more reports on the above market click here to Buy The Report
Global Brachytherapy Market is segmented by Product Type, Technique, End User, Application and region. Based on Product Type, the market is segmented into Seeds, Applicators and Afterloaders and Electronic Brachytherapy. Based on Technique, the market is segmented into High Dose Rate (HDR) and Low Dose Rate (LDR). Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on Application, the market is segmented into Gynecological Cancer, Prostate Cancer, breast cancer and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
By accounting for the biggest revenue share of 32.9% in 2023, the prostate cancer segment led the market. All individuals with localized prostate cancer can benefit from brachytherapy, which is a successful treatment option both alone and in combination with external beam radiation therapy. Brachytherapy's promising uses in the management of prostate cancer are what are propelling this market.
During the projected period, a CAGR of 7.6% is anticipated in the application category for breast cancer brachytherapy. The growing usage of brachytherapy in Accelerated Partial Breast Irradiation (APBI) is one of the main drivers behind the expansion of this industry. This market's expansion is also anticipated to be fueled by the increasing incidence of breast cancer.
With a market share of 71.2% in 2023, the HDR brachytherapy category led the industry. In most cases, the therapy is carried out as an outpatient operation to treat various cancers, including skin, cervical, prostate, head and neck, and breast cancer. Some of the elements influencing this segment's dominance are short procedure times, greater efficacy, and radiation protection. LDR after loaders are gradually being replaced with HDR after loaders all over the world because the maintenance of LDR systems is no longer typically guaranteed by the manufacturers.
Prostate cancer treatment is the main use of LDR brachytherapy. This market is anticipated to expand as a result of the release of novel products like GammaTile for the treatment of brain cancer. With Cesium-131 seeds, which have a superior adverse effect profile than other frequently used LDR isotopes, IsoRay was granted FDA 510K approval for this device.
To get detailed analysis on other segments, Request For Free Sample Report
With a 45.7% revenue share in 2023, North America dominated the brachytherapy market. Due to the benefits, it provides over conventional methods—namely, that it is a relatively safer and effective cancer treatment—brachytherapy is commonly utilized in North America. In 2022, Europe represented a share of almost 25,0%. Over the past five years, brachytherapy use in the European region has grown.
The market in Asia Pacific is anticipated to see the greatest CAGR. The area is home to more than 60% of the world's population and carries half of the burden of cancer globally. As a result of an unhealthy lifestyle, cancer incidence is increasing. Additionally, the limited availability of technologically sophisticated cancer therapies presents numerous potentials for the market players.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Demand For Minimally Invasive Procedures
Aging Population And Increasing Life Expectancy
High Initial Setup And Equipment Costs
Request Free Customization of this report to help us to meet your business objectives.
The global brachytherapy market is highly competitive, with several key players competing for market share. These companies focus on developing advanced brachytherapy technologies, expanding their product portfolios, and expanding their presence in emerging markets.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analyses, the global brachytherapy market is a rapidly growing segment of the healthcare industry. Brachytherapy, a type of radiation therapy, involves the precise placement of radioactive sources within or near the tumor site to deliver targeted radiation treatment. It is widely used in the treatment of various types of cancers, including prostate, breast, cervical, and skin cancer, among others. The market for brachytherapy is driven by several factors. The increasing prevalence of cancer worldwide, coupled with the rising aging population, is a significant driver for the market. According to the International Agency for Research on Cancer (IARC), the global incidence of cancer is projected to increase, leading to a growing demand for effective treatment options such as brachytherapy. The increasing prevalence of cancer and the shift towards minimally invasive treatments are expected to drive the demand for brachytherapy in the coming years.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 0.8 billion |
Market size value in 2032 | USD 1.64 billion |
Growth Rate | 8.3% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Brachytherapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Brachytherapy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Brachytherapy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Brachytherapy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Brachytherapy Market size was valued at USD 539.61 Million in 2023 and is poised to grow from USD 582.24 Million in 2024 to USD 1069.72 Million by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).
The global brachytherapy market is highly competitive, with several key players competing for market share. These companies focus on developing advanced brachytherapy technologies, expanding their product portfolios, and expanding their presence in emerging markets. 'Eckert & Ziegler BEBIG (Germany)', 'Varian Medical Systems, Inc. (United States)', 'Elekta AB (Sweden)', 'IsoAid LLC (United States)', 'Theragenics Corporation (United States)', 'C. R. Bard, Inc. (United States)', 'Boston Scientific Corporation (United States)', 'Isoray Inc. (United States)', 'Nucletron B.V. (Netherlands)', 'Huiheng Medical, Inc. (China)', 'iCAD, Inc. (United States)', 'Elekta AB (Sweden)', 'Nanobiotix SA (France)', 'BTG International Ltd. (United Kingdom)', 'GE Healthcare (United States)', 'IBA Worldwide (Belgium)', 'Cianna Medical, Inc. (United States)', 'Theragenics Corporation (United States)', 'C4 Imaging LLC (United States)', 'CIVCO Medical Solutions (United States)', 'RaySearch Laboratories AB (Sweden)', 'Hologic, Inc. (United States)'
Minimally invasive treatment procedures are preferred by patients due to reduced post-operative complications, shorter hospital stays, and faster recovery times. Brachytherapy is a minimally invasive treatment option that can be performed on an outpatient basis in many cases. The increasing demand for minimally invasive procedures contributes to the growth of the brachytherapy market.
Growing preference for organ-preserving treatments : Brachytherapy is often chosen as an organ-preserving treatment modality, particularly in cancers such as prostate, breast, and cervical cancer. It allows for targeted radiation delivery while minimizing damage to surrounding healthy tissues, thereby preserving organ function and improving quality of life for patients. The trend towards organ preservation and minimally invasive treatments has led to increased adoption of brachytherapy.
With a 45.7% revenue share in 2023, North America dominated the brachytherapy market. Due to the benefits, it provides over conventional methods—namely, that it is a relatively safer and effective cancer treatment—brachytherapy is commonly utilized in North America. In 2022, Europe represented a share of almost 25,0%. Over the past five years, brachytherapy use in the European region has grown.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35D2138
[email protected]
USA +1 351-333-4748